28/09/2026
ZAMBIA HOSTS REGIONAL MEDICINES REGULATORY TRAINING AND PEER LEARNING WORKSHOP
The Zambia Medicines Regulatory Authority (ZAMRA) Director-General, Mr. Makomani Siyanga, has called for stronger regional collaboration among medicines regulatory authorities to strengthen medicines regulation across Africa.
Mr. Siyanga said no single National Medicines Regulatory Authority (NMRA) can address the full scope of modern medicines regulation alone, adding that the region is stronger when regulators train together, inspect together and learn from one another’s experiences.
He was speaking when he officially opened the Regional Training and Peer Learning Workshop organised by the Common Market for Eastern and Southern Africa (COMESA), with support from the African Development Fund.
This was in a speech delivered on his behalf by Director - Licensing, Surveillance and Enforcement, Mr. Matthews Mwale.
The workshop, taking place from 28th to 30th September 2026 at Ciela Resort in Chongwe, is part of the implementation of the regional NMRA Capacity-Building Programme under the COMESA Support Towards Regional Pharmaceutical Sector Development (CSTRPSD).
The programme follows an assessment of NMRAs across the region, which recommended the establishment of Communities of Practice (CoPs) for medicines assessors, Good Manufacturing Practice (GMP) inspectors, pharmacovigilance (PV) officers and post-marketing surveillance (PMS) personnel.
Meanwhile, COMESA Acting Director - Industry and Agriculture Division, Ms. Esther Mwimba, said the initiative will focus on establishing functional Communities of Practice, implementable training and certification pathways, and a clear roadmap to help NMRAs identify their current capacity and areas for advancement.
The workshop provides a platform to validate the regional needs assessment, share knowledge and experiences, and advance regulatory convergence towards stronger medicines regulatory systems across COMESA.
These efforts contribute towards a harmonised and mutually trusted African regulatory architecture, anchored in the work of the African Medicines Agency (AMA) and the African Union Model Law on Medical Products Regulation.